Literature DB >> 21991898

A step toward personalized asthma treatment.

Jeffrey M Drazen.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21991898     DOI： 10.1056/NEJMe1102469

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Opportunities for cost reduction of medical care: part 3.

Authors:  Monte Malach; William J Baumol
Journal:  J Community Health       Date:  2012-08

2.  Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone.

Authors:  Chris Stockmann; Christopher A Reilly; Bernhard Fassl; Roger Gaedigk; Flory Nkoy; Bryan Stone; Jessica K Roberts; Derek A Uchida; J Steven Leeder; Catherine M T Sherwin; Michael G Spigarelli; Garold S Yost; Robert M Ward
Journal:  J Allergy Clin Immunol       Date:  2015-03-29       Impact factor: 10.793

3.  Lebrikizumab in the personalized management of asthma.

Authors:  Neil C Thomson; Manish Patel; Andrew D Smith
Journal:  Biologics       Date:  2012-09-14

Review 4.  Asthma phenotypes: the intriguing selective intervention with Montelukast.

Authors:  Cottini Marcello; Lombardi Carlo
Journal:  Asthma Res Pract       Date:  2016-08-12

Review 5.  Targeted therapy in severe asthma today: focus on immunoglobulin E.

Authors:  Girolamo Pelaia; Giorgio Walter Canonica; Andrea Matucci; Rossella Paolini; Massimo Triggiani; Pierluigi Paggiaro
Journal:  Drug Des Devel Ther       Date:  2017-06-29       Impact factor: 4.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.